Methods and Compositions for the Activation of Gamma-Delta T-Cells
Country:
US
Docket No:
436313-003136
Publication Number:
10,772,905
Patent Expiry:
01/13/203
Claims Scope:
Patent issued September 15, 2020.
Sequence Agnostic – Methods only
Method of treating cancer with a bisphosphonate drug in combination with a lentiviral particle encoding either shRNA or microRNA capable of inhibiting FDPS.
